微信小陈
微信小章| 产品名称： | Actinomyces israelii (Kruse) Lachner-Sandoval |
|---|---|
| 商品货号： | TS175084 |
| Strain Designations： | 287 CDC W726 |
| Isolation： | Human cervico-facial actinomycosis |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Serotype 1 |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Fa-serotyping and physiology |
| Medium： | ATCC® Medium 1490: Modified chopped meat medium |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Anaerobic |
| Name of Depositor： | A Howell |
| Chain of Custody： | ATCC <-- A Howell <-- R. Benham |
| References： | Thompson L. Isolation and comparison of Actionmyces from human and bovine infections. Proc. Staff Meet. Mayo Clin. 25: 81-86, 1950. Thompson L, Lovestedt SA. An actinomyces-like organism obtained from the human mouth. Proc. Staff Meet. Mayo Clin. 26: 169-175, 1951. Brock DW, Georg LK. Determination and analysis of Actinomyces israelii serotypes by fluorescent-antibody procedures. J. Bacteriol. 97: 581-588, 1969. PubMed: 4886286 Brock DW, Georg LK. Characterization of Actinomyces israelii serotypes 1 and 2. J. Bacteriol. 97: 589-593, 1969. PubMed: 4886287 |